ENTX
NASDAQ
$1.96
Entera Bio Ltd (ENTX)
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally administered large molecule therapies for unmet medical needs. The company is headquartered in Jerusalem, Israel.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $9 (+359.18%)
Market Cap
$83M
Free Cash Flow Yield
-11.03%
Beta (5Y)
0.61
Price Chart
Valuation
Market Cap$83M
P/S1547.08
P/B7.52
Profitability
EBITDA-$12M
EPS-$0.27
Financial Health
Free Cash Flow Yield-11.03%
Growth & Risk
Beta (5Y)0.61
Sharpe Ratio0.36